Obesity Theurapetic Development : Do You Really Need It? This Will Help You Decide!
Latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Pipeline Review, H2 2017, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery. Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Obesity - Pipeline Review, H2 2017 , provides comprehensive information on the therapeutics under development for Obesity (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research an...